Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
Clinical trial NCT03350035 · COMPLETED
Trial details
- NCT number
- NCT03350035
- Sponsor
- Marinus Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-09-18
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.